Tower Research Capital (TRC)’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$227K Buy
16,227
+14,549
+867% +$203K 0.01% 1662
2025
Q1
$22.9K Sell
1,678
-32,494
-95% -$443K ﹤0.01% 2833
2024
Q4
$655K Buy
34,172
+30,475
+824% +$584K 0.01% 887
2024
Q3
$84.1K Sell
3,697
-6,097
-62% -$139K ﹤0.01% 2356
2024
Q2
$127K Buy
9,794
+8,698
+794% +$113K ﹤0.01% 2408
2024
Q1
$19.2K Sell
1,096
-1,235
-53% -$21.6K ﹤0.01% 3036
2023
Q4
$50.8K Sell
2,331
-6,821
-75% -$149K ﹤0.01% 3127
2023
Q3
$140K Buy
9,152
+4,199
+85% +$64.4K ﹤0.01% 1718
2023
Q2
$118K Buy
4,953
+1,735
+54% +$41.3K ﹤0.01% 1910
2023
Q1
$82K Buy
3,218
+3,055
+1,874% +$77.8K ﹤0.01% 2054
2022
Q4
$5K Sell
163
-8,010
-98% -$246K ﹤0.01% 4924
2022
Q3
$167K Buy
8,173
+5,345
+189% +$109K ﹤0.01% 2103
2022
Q2
$33K Buy
2,828
+350
+14% +$4.08K ﹤0.01% 3284
2022
Q1
$45K Buy
2,478
+2,477
+247,700% +$45K ﹤0.01% 2825
2021
Q4
$0 Buy
+1
New ﹤0.01% 6601
2021
Q2
Sell
-118
Closed -$2K 5876
2021
Q1
$2K Sell
118
-1,274
-92% -$21.6K ﹤0.01% 5054
2020
Q4
$23K Buy
1,392
+1,234
+781% +$20.4K ﹤0.01% 3785
2020
Q3
$1K Buy
+158
New +$1K ﹤0.01% 4738
2019
Q3
Sell
-712
Closed -$22K 4541
2019
Q2
$22K Buy
712
+311
+78% +$9.61K ﹤0.01% 2130
2019
Q1
$17K Buy
401
+74
+23% +$3.14K ﹤0.01% 2377
2018
Q4
$15K Sell
327
-85
-21% -$3.9K ﹤0.01% 2177
2018
Q3
$34K Buy
412
+211
+105% +$17.4K ﹤0.01% 2002
2018
Q2
$19K Sell
201
-644
-76% -$60.9K ﹤0.01% 2475
2018
Q1
$89K Buy
+845
New +$89K 0.01% 1338
2017
Q4
Sell
-102
Closed -$14K 4148
2017
Q3
$14K Buy
+102
New +$14K ﹤0.01% 2926
2016
Q2
Hold
0
5036
2016
Q1
Hold
0
5012
2015
Q4
Sell
-3
Closed -$1K 5113
2015
Q3
$1K Buy
+3
New +$1K ﹤0.01% 3687
2015
Q2
Sell
-36
Closed -$17K 5110
2015
Q1
$17K Buy
36
+27
+300% +$12.8K ﹤0.01% 2387
2014
Q4
$5K Hold
9
﹤0.01% 2747
2014
Q3
$9K Buy
+9
New +$9K ﹤0.01% 2908